These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 21954966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    Kim E, You M, Pikalov A, Van-Tran Q, Jing Y.
    BMC Psychiatry; 2011 Jan 07; 11():6. PubMed ID: 21214937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ, Keck PE, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.
    Pharmacotherapy; 2007 Jan 07; 27(1):27-35. PubMed ID: 17192159
    [Abstract] [Full Text] [Related]

  • 7. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J, Tien YY, Cohen LJ, Sclar DA, Liu D, Blodgett EG, Engle J.
    Clin Ther; 2009 Dec 07; 31(12):2931-9. PubMed ID: 20110033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ, Fabian TJ, Saul MI, Haskett R, Coley KC.
    J Psychiatr Pract; 2013 Jul 07; 19(4):288-95. PubMed ID: 23852103
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics.
    Ng-Mak D, Halpern R, Rajagopalan K, Loebel A.
    Curr Med Res Opin; 2019 Feb 07; 35(2):211-219. PubMed ID: 29625538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population.
    Yu AP, Atanasov P, Ben-Hamadi R, Birnbaum H, Stensland MD, Philips G.
    Value Health; 2009 Feb 07; 12(5):708-15. PubMed ID: 19508658
    [Abstract] [Full Text] [Related]

  • 18. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D, Tandon N, Lafeuille MH, Kamstra R, Emond B, Lefebvre P, Joshi K.
    Clin Ther; 2017 Oct 07; 39(10):1972-1985.e2. PubMed ID: 28919292
    [Abstract] [Full Text] [Related]

  • 19. Hospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications.
    Gianfrancesco F, Wang RH, Pesa J, Rajagopalan K.
    Int J Clin Pract; 2006 Nov 07; 60(11):1419-24. PubMed ID: 17073838
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.